Nl-Fr

View abstract

This abstract is assigned to session Free Papers - Oral Presentations II
Presentation preference Oral presentation
TitleSystemic Immunomodulatory Therapy in the Uveitis Clinic: 10-year profile
Accept poster if oral is not possible ?Yes
PurposeImmunomodulatory therapy (IMT) in non-infectious uveitis aims to achieve durable remission. Data on sustained remission after withdrawn of IMT are limited. Our primary purpose was to characterize the IMT profile in patients with idiopathic uveitis (IU) regarding duration and discontinuation of IMT and pattern of disease relapse.
MethodsRetrospective review of patients with idiopathic uveitis under IMT evaluated in the past
ResultsA total of 111 patients with idiopathic uveitis under IMT were included, divided into 5 anatomic groups: anterior uveitis (30;27%), intermediate uveitis (14;12.6%), posterior uveitis (31;27.9%), panuveitis (23;20.7%) and scleritis (13;11.7%). The mean follow-up time was 94.9±52.6 months [12-264]. 84 patients (76.4%) presented bilateral involvement. Methotrexate was the most widely used IMT (n=59,53.2%) followed by cyclosporine (n=33,29.7%), azathioprine (n=10,9%) and adalimumab (n=9,8.1%). The median duration of treatment was 36 months (IQR 24-60), with 67 patients (60.4%) under IMT for at least 3 years. Before treatment, patients presented a mean of 2.1±1.4 flare-ups/year, which significantly decreased to a mean of 0.6±0.7 relapses/year after IMT (p<0.001) in all anatomic groups. From the 53 patients (47.7%) who stopped IMT, 14 (26.4%) relapsed. 91.3% of the patients treated for >3 years and 100% of the patients treated for >4 years did not relapse. The group without uveitis recurrence was under IMT for a significantly longer period before stopping (51.2±35 vs 26.4±12, p<0.001), comparing to the patients who relapsed.
ConclusionThe decision to stop IMT based on a 3-year remission period appears to be a safe approach preventing recurrent sight threatening inflammation.
Conflict of interestNo
1
Last nameFERREIRA
Initials of first name(s)AM
DepartmentOphthalmology
CityPorto
CountryPortugal
2
Last nameSilva
Initials of first name(s)M
DepartmentOphthalmology
CityPorto
CountryPortugal
3
Last namePedrosa
Initials of first name(s)C
DepartmentOphthalmology
CityPorto
CountryPortugal
4
Last nameOliveira-Ferreira
Initials of first name(s)C
DepartmentOphthalmology
CityPorto
CountryPortugal
5
Last nameTorres-Costa
Initials of first name(s)S
DepartmentOphthalmology
CityPorto
CountryPortugal
6
Last nameTorrão
Initials of first name(s)L
DepartmentOphthalmology
CityPorto
CountryPortugal
7
Last nameFigueira
Initials of first name(s)L
DepartmentOphthalmology
CityPorto
CountryPortugal
8
Last nameRodrigues-Araújo
Initials of first name(s)J
DepartmentOphthalmology
CityPorto
CountryPortugal